247 related articles for article (PubMed ID: 32024821)
1. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
2. Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors.
Arumov A; Liyanage PY; Trabolsi A; Roberts ER; Li L; Ferreira BCLB; Gao Z; Ban Y; Newsam AD; Taggart MW; Vega F; Bilbao D; Leblanc RM; Schatz JH
Cancer Res; 2021 Feb; 81(3):763-775. PubMed ID: 33177062
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle.
Du Y; Fan K; Zhang H; Li L; Wang P; He J; Ding S; Yan X; Tian J
Nanomedicine; 2018 Oct; 14(7):2259-2270. PubMed ID: 30056091
[TBL] [Abstract][Full Text] [Related]
4. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
[TBL] [Abstract][Full Text] [Related]
5. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
6. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
7. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
Liang M; Fan K; Zhou M; Duan D; Zheng J; Yang D; Feng J; Yan X
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14900-5. PubMed ID: 25267615
[TBL] [Abstract][Full Text] [Related]
8. Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting.
Jiang B; Jia X; Ji T; Zhou M; He J; Wang K; Tian J; Yan X; Fan K
Sci China Life Sci; 2022 Feb; 65(2):328-340. PubMed ID: 34482518
[TBL] [Abstract][Full Text] [Related]
9. Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery.
Chen Z; Zhai M; Xie X; Zhang Y; Ma S; Li Z; Yu F; Zhao B; Zhang M; Yang Y; Mei X
Mol Pharm; 2017 Sep; 14(9):3087-3097. PubMed ID: 28728419
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
12. H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.
Mazzucchelli S; Truffi M; Baccarini F; Beretta M; Sorrentino L; Bellini M; Rizzuto MA; Ottria R; Ravelli A; Ciuffreda P; Prosperi D; Corsi F
Sci Rep; 2017 Aug; 7(1):7505. PubMed ID: 28790402
[TBL] [Abstract][Full Text] [Related]
13. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
[TBL] [Abstract][Full Text] [Related]
14. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
[TBL] [Abstract][Full Text] [Related]
15. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.
Fan K; Jia X; Zhou M; Wang K; Conde J; He J; Tian J; Yan X
ACS Nano; 2018 May; 12(5):4105-4115. PubMed ID: 29608290
[TBL] [Abstract][Full Text] [Related]
16. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.
Li L; Fang CJ; Ryan JC; Niemi EC; Lebrón JA; Björkman PJ; Arase H; Torti FM; Torti SV; Nakamura MC; Seaman WE
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3505-10. PubMed ID: 20133674
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
18. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
[TBL] [Abstract][Full Text] [Related]
20. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
